Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the influence of genetic polymorphism of cytochrome
P450 3A5 on pharmacokinetics of maraviroc and its oxidative metabolites